High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?

医学 前列腺癌 放射科 前列腺 离格 放射治疗 谷氨酸羧肽酶Ⅱ 生化复发 高强度聚焦超声 多参数磁共振成像 回顾性队列研究 超声波 核医学 复发性前列腺癌 队列 前列腺特异性抗原 活检 癌症 聚焦超声 原发性肿瘤
作者
Alexander Maurer,Urs J. Muehlematter,Thibika Sivakumar,Ashkan Mortezavi,Jakob Heimer,Basil Kaufmann,Stephan Beintner-Skawran,Michael Messerli,Martin W. Huellner,Daniel Eberli,Irene A. Burger
出处
期刊:Journal of nuclear medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:67 (2): 239-245 被引量:1
标识
DOI:10.2967/jnumed.125.271318
摘要

High-intensity focused ultrasound (HIFU) is an increasingly used, locally ablative therapy option in localized prostate cancer (PCa). Multiparametric MRI (mpMRI) is currently used for tumor delineation. However, up to 56% of patients will have recurrent disease, defined as International Society of Urological Pathology (ISUP) grade of 2 or greater on follow-up biopsies within 3 y. The objectives of this study were to evaluate recurrence and failure-free survival (FFS) rates in patients treated with HIFU after undergoing prostate-specific membrane antigen (PSMA) PET and to compare delineation and scoring for biopsy-proven lesions between imaging techniques (PSMA PET vs. mpMRI). Methods: This single-center retrospective cohort study included all patients who were scheduled for HIFU between June 2017 and May 2022 and underwent a PSMA PET scan within 6 mo before planned HIFU for initial therapy of low-risk or intermediate-risk PCa (primary HIFU) or local recurrence after radiotherapy (salvage HIFU). Outcomes assessed included FFS, defined as the absence of ISUP grade 2 or greater on follow-up biopsies, progression on imaging, or biochemical recurrence. Tumor detection on mpMRI and PSMA PET was compared using PRIMARY and Prostate Imaging Reporting and Data System (PI-RADS) 2.1 scores for patients with adequate mpMRI and PSMA PET within 6 mo of HIFU. Results: Of the 26 patients included in the cohort, 3 (12%) did not undergo HIFU after the PSMA PET scan because of PCa upstaging. Of the remaining 23 patients, 9 (39%) were treated for recurrent disease and 14 (61%) for primary disease. Over a mean follow-up time of 3.2 y, 15 patients (65%; 95% CI, 42.7%–83.6%) were free of disease at the last follow-up. Eight patients (35%) experienced recurrent or residual disease within 3 y. Image analysis was performed for 18 patients, for a total of 23 lesions, with mean PRIMARY and PI-RADS 2.1 scores of 4.1 (range, 2–5), and 3.3 (range, 2–5), respectively. Lesion detection was rated superior on PET over mpMRI for 12 lesions, whereas mpMRI was superior for 1 lesion. Conclusion: PSMA PET scans performed before HIFU identified 12% of patients who were unsuitable for treatment. The overall improved FFS rate and higher PRIMARY score, when compared with the existing literature, suggest a potential benefit of PSMA PET for tumor delineation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jumbaumba完成签到,获得积分10
刚刚
俏皮以旋完成签到,获得积分10
刚刚
www完成签到,获得积分10
1秒前
CodeCraft的应助被傅纶军采纳,获得10
1秒前
NexusExplorer的应助被公西钧采纳,获得10
1秒前
小于发布了新的文献求助10
2秒前
2秒前
谦让的沛蓝发布了新的文献求助100
2秒前
科研通AI6.3的应助被zombie采纳,获得10
3秒前
俏皮以旋发布了新的文献求助10
5秒前
6秒前
猪猪完成签到 ,获得积分10
6秒前
噜妹完成签到 ,获得积分10
6秒前
隐形曼青的应助被456qwe采纳,获得10
6秒前
Huang完成签到 ,获得积分0
7秒前
8秒前
斯文败类的应助被Lu采纳,获得10
8秒前
Hello的应助被小于采纳,获得10
8秒前
niuniuniu发布了新的文献求助10
8秒前
顾矜的应助被zhang采纳,获得10
9秒前
椰子汁完成签到,获得积分10
9秒前
chenyi完成签到 ,获得积分10
10秒前
疯狂的聋五完成签到,获得积分10
10秒前
77发布了新的文献求助10
10秒前
11秒前
Wyf发布了新的文献求助10
11秒前
12秒前
13秒前
15秒前
jcz完成签到,获得积分10
15秒前
16秒前
科研通AI6.2的应助被cencen采纳,获得10
17秒前
公西钧发布了新的文献求助10
17秒前
傅纶军发布了新的文献求助10
17秒前
17秒前
18秒前
细腻戒指完成签到,获得积分10
18秒前
18秒前
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962